Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma

MLA

Marwan Fakih, et al. “Phase II Study of Weekly Intravenous Oxaliplatin Combined with Oral Daily Capecitabine and Radiotherapy with Biologic Correlates in Neoadjuvant Treatment of Rectal Adenocarcinoma.” International Journal of Radiation Oncology, Biology, Physics, vol. 72, no. 3, Oct. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7b5a25868a7347a87f46d0de10d0bb5f&authtype=sso&custid=ns315887.

APA

Marwan Fakih, Ashwani Rajput, Chris Andrews, Karoly Toth, Charles LeVea, Lakshmi Pendyala, Gary Y. Yang, Youcef M. Rustum, Kelli M. BullardDunn, Ajithkumar Puthillath, Young-Mee Park, & Mary Ellen Ross. (2007). Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics, 72(3).

Chicago

Marwan Fakih, Ashwani Rajput, Chris Andrews, Karoly Toth, Charles LeVea, Lakshmi Pendyala, Gary Y. Yang, et al. 2007. “Phase II Study of Weekly Intravenous Oxaliplatin Combined with Oral Daily Capecitabine and Radiotherapy with Biologic Correlates in Neoadjuvant Treatment of Rectal Adenocarcinoma.” International Journal of Radiation Oncology, Biology, Physics 72 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7b5a25868a7347a87f46d0de10d0bb5f&authtype=sso&custid=ns315887.